Simeoli, C.
Ferrigno, R.
De Martino, M. C.
Iacuaniello, D.
Papa, F.
Angellotti, D.
Pivonello, C.
Patalano, R.
Negri, M.
Colao, A.
Pivonello, R.
Article History
Received: 12 January 2018
Accepted: 18 June 2019
First Online: 16 July 2019
Compliance with ethical standards
:
: C.S. has been occasional consultant for Shire and Ipsen. R.F., M.C.D.M., D.I., F.P., D.A., C.P., Ro.Pa., and M.N. have nothing to disclose. A.C. has been Principal Investigator of Research Studies for Novartis, Ipsen, and Pfizer; received research grants from Novartis. Ro.Pi. has been Principal Investigator of Research Studies for Novartis, HRA Pharma, Ipsen, Shire, Corcept Therapeutics, Cortendo AB; received research grants from Novartis, Pfizer, Ipsen, HRA Pharma, Shire, IBSA; has been an occasional consultant for Novartis, Ipsen, Pfizer, Shire, HRA Pharma, Cortendo AB, Ferring and Italfarmaco; and has received fees and honoraria for presentations from Novartis, Shire.
: All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: This article does not contain any studies with animals performed by any of the authors.
: Informed consent was obtained from all individual participants included in the study.